SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
Preprint
- 14 October 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Background Patients receiving dialysis are a sentinel population for groups at high risk for death and disability from COVID-19. Understanding correlates of protection post-vaccination can inform immunization and mitigation strategies. Methods Monthly since January 2021, we tested plasma from 4791 patients receiving dialysis for antibodies to the receptor-binding domain (RBD) of SARS-CoV-2 using a high-throughput assay. We qualitatively assessed the proportion without a detectable RBD response and among those with a response, semiquantitative median IgG index values. Using a nested case-control design, we matched each breakthrough case to five controls by age, sex, and vaccination-month to determine whether peak and pre-breakthrough RBD IgG index values were associated with risk for infection post-vaccination. Results Among 2563 vaccinated patients, the proportion without a detectable RBD response increased from 6.6% [95% CI 5.5-8.1] in 14-30 days post-vaccination to 20.2% [95% CI 17.1-23.8], and median index values declined from 92.7 (95% CI 77.8-107.5) to 3.7 (95% CI 3.1-4.3) after 5 months. Persons with SARS-CoV-2 infection prior-to-vaccination had higher peak index values than persons without prior infection, but values equalized by 5 months (p=0.230). Breakthrough infections occurred in 56 patients, with samples collected a median of 21 days pre-breakthrough. Peak and pre-breakthrough RBD values <23 (equivalent to <506 WHO BAU/mL) were associated with higher odds for breakthrough infection (OR: 3.7 [95% CI 2.0-6.8] and 9.8 [95% CI 2.9-32.8], respectively). Conclusions The antibody response to SARS-CoV-2 vaccination wanes rapidly, and in persons receiving dialysis, the persisting antibody response is associated with risk for breakthrough infection.Keywords
This publication has 27 references indexed in Scilit:
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack RateJournal of Clinical Microbiology, 2020
- Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody testsJournal of Clinical Virology, 2020
- Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an OutbreakMorbidity and Mortality Weekly Report (MMWR), 2018
- Linear quantile regression models for longitudinal experiments: an overviewMETRON, 2015
- Influenza A/H1N1 Vaccine in Patients Treated by Kidney Transplant or DialysisClinical Journal of the American Society of Nephrology, 2011
- Contributions of humoral and cellular immunity to vaccine-induced protection in humansVirology, 2011
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Quantile RegressionPublished by SAGE Publications ,2007
- Prospective analysis of the factors influencing the antibody response to hepatitis b vaccine in hemodialysis patientsAmerican Journal of Kidney Diseases, 1997
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Hemodialysis PatientsAmerican Journal of Nephrology, 1992